| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,898 |
4,951 |
$232K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,840 |
2,975 |
$122K |
| 94060 |
|
1,573 |
1,483 |
$52K |
| 95923 |
|
507 |
490 |
$45K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,339 |
1,943 |
$38K |
| 93922 |
|
627 |
591 |
$31K |
| 99406 |
|
3,437 |
2,556 |
$26K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
417 |
355 |
$18K |
| S8301 |
Infection control supplies, not otherwise specified |
999 |
770 |
$17K |
| 92552 |
|
738 |
702 |
$16K |
| 80305 |
|
1,918 |
1,783 |
$15K |
| 92550 |
|
759 |
721 |
$11K |
| 93000 |
|
902 |
834 |
$9K |
| 92587 |
|
438 |
420 |
$6K |
| 99215 |
Prolong outpt/office vis |
91 |
78 |
$5K |
| 81002 |
|
3,087 |
2,786 |
$5K |
| 90756 |
|
252 |
239 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
146 |
135 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
217 |
210 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
26 |
25 |
$2K |
| 92546 |
|
22 |
21 |
$1K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,084 |
924 |
$1K |
| 92540 |
|
22 |
21 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
93 |
87 |
$1K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
712 |
463 |
$1K |
| 94726 |
|
94 |
72 |
$750.12 |
| 90661 |
|
33 |
32 |
$725.00 |
| 0513F |
|
35 |
33 |
$480.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,229 |
893 |
$252.66 |
| 82947 |
|
17 |
15 |
$41.07 |
| 94760 |
|
68 |
55 |
$28.87 |
| 82948 |
|
24 |
12 |
$12.69 |
| 82962 |
|
1,890 |
1,397 |
$4.24 |
| 95115 |
|
18 |
12 |
$1.30 |
| 3077F |
|
644 |
521 |
$0.01 |
| 3074F |
|
5,430 |
4,232 |
$0.00 |
| 3075F |
|
1,240 |
1,050 |
$0.00 |
| 3080F |
|
412 |
334 |
$0.00 |
| 3079F |
|
2,348 |
1,999 |
$0.00 |
| 1101F |
|
28 |
28 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
31 |
29 |
$0.00 |
| 1111F |
|
122 |
105 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
84 |
77 |
$0.00 |
| 96127 |
|
73 |
72 |
$0.00 |
| 3044F |
|
26 |
26 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
193 |
168 |
$0.00 |
| 3011F |
|
39 |
37 |
$0.00 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
28 |
28 |
$0.00 |
| G8924 |
Spirometry results documented (fev1/fvc < 70%) |
33 |
31 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
97 |
66 |
$0.00 |
| G8925 |
Spirometry test results demonstrate fev1 >= 60% fev1/fvc >= 70%, predicted or patient does not have copd symptoms |
15 |
13 |
$0.00 |
| 1036F |
|
79 |
70 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
29 |
29 |
$0.00 |
| 1125F |
|
91 |
88 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
30 |
25 |
$0.00 |
| 1126F |
|
13 |
13 |
$0.00 |
| 3017F |
|
16 |
13 |
$0.00 |
| 3078F |
|
4,720 |
3,671 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
104 |
88 |
$0.00 |
| 1160F |
|
357 |
312 |
$0.00 |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
28 |
28 |
$0.00 |
| 3023F |
|
73 |
68 |
$0.00 |
| 99401 |
|
34 |
30 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
135 |
119 |
$0.00 |
| G9695 |
Long-acting inhaled bronchodilator prescribed |
69 |
65 |
$0.00 |
| 4004F |
|
14 |
13 |
$0.00 |
| Q2037 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) |
39 |
31 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
25 |
25 |
$0.00 |
| 96160 |
|
29 |
29 |
$0.00 |
| 99483 |
Prolong outpt/office vis |
42 |
26 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
81 |
74 |
$0.00 |
| 99497 |
|
61 |
58 |
$0.00 |
| 4040F |
|
16 |
14 |
$0.00 |
| 1159F |
|
52 |
43 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
59 |
52 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
17 |
15 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
27 |
27 |
$0.00 |